Neogen Co. (NASDAQ:NEOG) Director James L. Herbert sold 5,000 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $60.73, for a total value of $303,650.00. Following the transaction, the director now directly owns 671,484 shares in the company, valued at approximately $40,779,223.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Shares of NASDAQ NEOG traded down $1.61 during mid-day trading on Thursday, hitting $56.79. The company had a trading volume of 1,757 shares, compared to its average volume of 183,357. The company has a market cap of $3.04 billion, a price-to-earnings ratio of 46.93, a price-to-earnings-growth ratio of 5.24 and a beta of 1.33. Neogen Co. has a 12 month low of $50.60 and a 12 month high of $97.38.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Tuesday, March 26th. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.02). The company had revenue of $97.70 million during the quarter, compared to the consensus estimate of $102.55 million. Neogen had a return on equity of 10.48% and a net margin of 14.96%. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period last year, the business posted $0.32 EPS. Equities research analysts forecast that Neogen Co. will post 1.12 earnings per share for the current year.

A number of research firms have commented on NEOG. BidaskClub raised Neogen from a “strong sell” rating to a “sell” rating in a report on Wednesday, March 20th. Craig Hallum raised Neogen from a “hold” rating to a “buy” rating and set a $62.76 target price on the stock in a report on Tuesday, March 19th. ValuEngine raised Neogen from a “hold” rating to a “buy” rating in a report on Thursday, January 24th. Zacks Investment Research downgraded Neogen from a “hold” rating to a “sell” rating in a report on Wednesday, May 1st. Finally, Guggenheim began coverage on Neogen in a report on Thursday. They set a “neutral” rating on the stock. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $62.76.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Creative Planning raised its stake in Neogen by 2.4% during the 1st quarter. Creative Planning now owns 7,554 shares of the company’s stock valued at $434,000 after acquiring an additional 174 shares in the last quarter. Arizona State Retirement System raised its stake in Neogen by 0.3% during the 1st quarter. Arizona State Retirement System now owns 80,344 shares of the company’s stock valued at $4,611,000 after acquiring an additional 272 shares in the last quarter. Manchester Capital Management LLC raised its stake in Neogen by 105.6% during the 1st quarter. Manchester Capital Management LLC now owns 590 shares of the company’s stock valued at $34,000 after acquiring an additional 303 shares in the last quarter. Captrust Financial Advisors raised its stake in Neogen by 47.0% during the 4th quarter. Captrust Financial Advisors now owns 970 shares of the company’s stock valued at $55,000 after acquiring an additional 310 shares in the last quarter. Finally, McCollum Christoferson Group LLC raised its stake in Neogen by 0.3% during the 1st quarter. McCollum Christoferson Group LLC now owns 124,921 shares of the company’s stock valued at $7,169,000 after acquiring an additional 334 shares in the last quarter. 88.81% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: Neogen Co. (NEOG) Director Sells 5,000 Shares of Stock” was reported by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.dailypolitical.com/2019/05/23/insider-selling-neogen-co-neog-director-sells-5000-shares-of-stock.html.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Recommended Story: Outstanding Shares, Buying and Selling Stocks

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.